Australia
Click the 'X' in the top right corner to close this window.
BioForum Quarterly Review - July 2010
Every quarter, BioForum reports the Australian and US listed Biotechnology market performance. It includes quarterly and annual reporting on the changes in the PwC Australian Life Sciences Sector, the NASDAQ Life Sciences Sector and changes in the sub sectors - pharmaceutical/biotechnology and medical devices.BioForum Quarterly Review - Q3 FY10 - Edition 32
We are proud to launch our PricewaterhouseCoopers, quarterly BioForum report edition 32 Q3 FY10. The BioForum is a reference point, reviewing quarterly data and news for the Australian and US life science markets, including market performance, initial and secondary capital raising, clinical milestones, partnerships and mergers & acquisitions.
This edition features two thought leadership articles. One article is on the expected impact on the life sciences sector of legislation passed recently in the US, the Health Care and Education Affordability Reconciliation Act of 2010.
A second article provides background on a recent PwC publication, Global pharma looks to India, which discusses how India now has a growing and increasingly sophisticated pharmaceutical industry of its own. This edition also includes PwC's regular data and news review of the Australian and US Life Science markets for the quarter.
To download BioForum [PDF 1 MB] please submit the following form.
